Research arising from the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) indicates that radiopharmaceuticals, "which deliver radiation therapy directly and specifically to cancer cells" can reduce both the short and long-term effects of radiation therapy treatment. According to Dr. Charles Kenos of NCI CTEP, radiopharmaceuticals will "transform radiation oncology in the next 10 to 15 years."
To read more about this study, click here.
No comments:
Post a Comment